Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma

RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT

(2015) Isabelle Coupienne et al.   LASERS IN SURGERY AND MEDICINE

Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

(2012) J. B. Bachet et al.   ANNALS OF ONCOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma

(2012) Sarah B. Fisher et al.   CANCER

Systemic treatment of advanced pancreatic cancer

(2012) Volker Heinemann et al.   CANCER TREATMENT REVIEWS

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

(2012) Liming Sun et al.   CELL

High Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma

(2012) Xianhui Xu et al.   JOURNAL OF GASTROINTESTINAL SURGERY

New components of the necroptotic pathway

(2012) Zhenru Zhou et al.   Protein & Cell

Differential Expression of ERCC1 in Pancreas Adenocarcinoma: High Tumor Expression is Associated with Earlier Recurrence and Shortened Survival after Resection

(2011) Shishir K. Maithel et al.   ANNALS OF SURGICAL ONCOLOGY

Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

(2011) D. Ansari et al.   BRITISH JOURNAL OF SURGERY

Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer

(2011) X. Liu et al.   CANCER RESEARCH

Many stimuli pull the necrotic trigger, an overview

(2011) N Vanlangenakker et al.   CELL DEATH AND DIFFERENTIATION

Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis

(2011) N. B. Jamieson et al.   CLINICAL CANCER RESEARCH

The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs

(2011) Tencho Tenev et al.   MOLECULAR CELL

GLUT-1 Expression in Pancreatic Neoplasia

(2011) Olca Basturk et al.   PANCREAS

A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling

(2011) C. Cotta-Ramusino et al.   SCIENCE

ERCC1: impact in multimodality treatment of upper gastrointestinal cancer

(2010) Ralf Metzger et al.   Future Oncology

Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems

(2010) Kevin A. Maupin et al.   PLoS One

The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis

(2010) P. Vandenabeele et al.   Science Signaling

FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

(2009) Huadong Pei et al.   CANCER CELL

DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

(2009) Christine A. Iacobuzio-Donahue et al.   JOURNAL OF CLINICAL ONCOLOGY

A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability

(2009) Renee D. Paulsen et al.   MOLECULAR CELL

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

(2008) James J. Farrell et al.   GASTROENTEROLOGY